Pirfenidone CAS 53179-13-8 Tsafta ≥99.0% IPF

Takaitaccen Bayani:

Sunan Chemical: Pirfenidone

Saukewa: 53179-13-8

Tsafta: ≥99.0%

Bayyanar: Fari zuwa Haske Yellow Crystalline Foda

Kyakkyawan inganci, Samar da Kasuwanci

Don maganin Fibrosis na huhu na Idiopathic (IPF)

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Ƙarfafawa Tare da Babban Tsafta, Samar da Kasuwanci
Sunan Chemical: Pirfenidone
Saukewa: 53179-13-8

Abubuwan Sinadarai:

Sunan Sinadari Pirfenidone
Makamantu Perfenidone;5-Methyl-1-Phenylpyridine-2(1H) -daya;PFD;S-7701;AMR-69
Lambar CAS 53179-13-8
Lambar CAT RF-API108
Matsayin Hannun jari A Stock
Tsarin kwayoyin halitta Saukewa: C12H11
Nauyin Kwayoyin Halitta 185.22
Matsayin narkewa 96.0 zuwa 97.0 ℃
Solubility Mai narkewa a cikin DMSO
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari zuwa Haske Rawaya Crystalline Foda
Ganewa IR
Tsafta ≥99.0%
Asara akan bushewa ≤0.50%
Sulfated ash ≤0.20%
Rashin Tsabtace Guda Daya ≤0.50%
Jimlar ƙazanta ≤1.0%
Karfe masu nauyi ≤20ppm
Matsayin Gwaji Matsayin Kasuwanci
Amfani API, Idiopathic Fibrosis Pulmonary (IPF)

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi.

Amfani:

1

FAQ:

Aikace-aikace:

Pirfenidone (CAS: 53179-13-8) yana cikin rukunin magunguna da ake kira magungunan antifibrotic.Pirfenidone ya nuna aiki a cikin yanayin fibrotic da yawa, ciki har da na huhu, koda da hanta.Yana shafar tsarin garkuwar jikin ku kuma yana rage adadin fibrosis (tabo) a cikin huhu.Pirfenidone yana ɗaya daga cikin magunguna biyu da aka yarda a Kanada don magance Fibrosis na Pulmonary Idiopathic (IPF).Pirfenidone shine mai hanawa don samar da TGF-β da kuma TGF-β yana haɓaka samar da collagen, yana rage samar da TNF-α da IL-1β, kuma yana da anti-fibrotic da anti-inflammatory Properties.An fara yarda da shi a Japan don maganin marasa lafiya tare da fibrosis na huhu na huhu bayan gwaje-gwaje na asibiti, a ƙarƙashin sunan kasuwanci na Pirespa ta Shionogi, a cikin 2008. An amince da shi don amfani a cikin Tarayyar Turai a 2011, a Kanada a 2012, kuma a cikin Amurka a watan Oktoba 2014.

Ku rubuta sakonku anan ku aiko mana